Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses

Journal of Experimental Medicine

Volumn 205, Issue 1, 2008, Pages 35-42

  Lazarczyk, Maciej ^a,b   Pons, Christian ^a   Mendoza, José Andrès ^a,c   Cassonnet, Patricia ^a   Jacob, Yves ^a   Favre, Michel ^a  

^a INSTITUT PASTEUR   (France)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c Universidad De Los Andes Facultad de Medicina   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PROTEIN EVER 1; PROTEIN EVER 2; UNCLASSIFIED DRUG; ZINC TRANSPORTER; CATION TRANSPORT PROTEIN; CYTOKINE; SLC30A1 PROTEIN, HUMAN; SMALL INTERFERING RNA; TMC6 PROTEIN, HUMAN; TMC8 PROTEIN, HUMAN; ZINC;

ARTICLE; DOWN REGULATION; GENE CONTROL; GENE MUTATION; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN LOCALIZATION; WART VIRUS; ZINC METABOLISM; CHEMISTRY; EPIDERMODYSPLASIA VERRUCIFORMIS; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; METABOLISM; PAPILLOMA VIRUS; PHYSIOLOGY; TUMOR CELL LINE; TWO HYBRID SYSTEM; VIROLOGY; VIRUS GENOME; VIRUS INFECTION;

CATION TRANSPORT PROTEINS; CELL LINE, TUMOR; CYTOKINES; EPIDERMODYSPLASIA VERRUCIFORMIS; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOME, VIRAL; HUMANS; MEMBRANE PROTEINS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RNA, SMALL INTERFERING; TWO-HYBRID SYSTEM TECHNIQUES; ZINC;

EID: 38749086503     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20071311     Document Type: Article

References (30)

1. Orth, G. 1999. Papillomaviruses - human (Papovaviridae): General Features. In Encyclopedia of Virology. Second edition. R.G. Webster and A. Granhoff, editors. Academic Press Ltd., London. 1105-1114.
2. Howley, P.M., and D.R. Lowy. 2001. Papillomaviruses and their replication. Fields Virology. Vol. 2. Lippincott Williams and Wilkins, Philadelphia. 2197-2230.
3. zur Hausen, H. 2002. Papillomavirus and cancer: from basic studies to clinical application. Nat. Rev. Cancer. 2:342-350.
4. Orth, G. 1987. Epidermodysplasia verruciformis. In The Papovaviridae: The Papillomaviruses. N.P. Salzman and P.M. Howley, editors. Vol. 2. Plenum Press New York. 199-243.
5. Majewski, S., S. Jablonska, and G. Orth. 1997. Epidermodysplasia verruciformis. Immunological and nonimmunological surveillance mechanisms: role in tumor progression. Clin. Dermatol. 15:321-334.
6. Antonsson, A., O. Forslund, H. Ekberg, G. Sterner, and B.G. Hansson. 2000. The ubiquity and impressive skin papillomaviruses suggest a commensalic nature of these viruses. J. Virol. 74:11636-11641.
7. Struijk, L., J.N. Bouwes Bavinck, P. Wanningen, E. van der Meijden, R.G. Westendorp, I.J. Ter Schegget, and M.C. Feltkamp. 2003. Presence of human papillomavirus DNA in plucked eyebrow hairs is associated with a history of cutaneous squamous cell carcioma. J. Invest. Dermatol. 121:1531-1535.
8. Favre, M., G. Orth, S. Majewski, S. Baloul, A. Pura, and S. Jablonska. 1998. Psoriasis: a possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. J. Invest. Dermatol. 110:311-317.
9. Favre, M., S. Majewski, B. Noszczyk, F. Maienfisch, A. Pura, G. Orth, and S. Jablonska. 2000. Antibodies to human papillomavirus type 5 are generated in epidermal repair processes. J. Invest. Dermatol. 114:403-407.
10. Pfister, H. 2003. Chapter 8: human papillomavirus and skin cancer. J. Natl. Cancer Inst. 31:52-56.
11. Orth, G. 2005. Human papillomaviruses associated with epidermodysplasia verruciformis in non-melanoma skin cancers: guilty or innocent? J. Invest. Dermatol. 125:xii-xiii.
12. Ramoz, N., A. Taieb, L.-A. Rueda, L.-S. Montoya, B. Bouadjar, M. Favre, and G. Orth. 2000. Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25. J. Invest. Dermatol. 114:1148-1153.
13. Ramoz, N., L.-A. Rueda, B. Bouadjar, L.-S. Montoya, G. Orth, and M. Favre. 2002. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat. Genet. 32:579-581.
14. Keresztes, G., H. Mutai, and S. Heller. 2003. TMC and EVER genes belong to a larger novel family, the TMC gene family encoding transmembrane proteins. BMC Genomics. 4:24-45.
15. Fields, S., and O. Song. 1989. A novel genetic system to detect protein-protein interactions. Nature. 340:245-246.
16. Bravo, I.G., and A. Alonso. 2004. Mucosal human papillomaviruses encode four different E5 proteins whose chemistry and phylogeny correlate with malignant or benign growth. J. Virol. 78:13613-13626.
17. Mendoza, J.A., Y. Jacob, P. Cassonnet, and M. Favre. 2006. Human papillomavirus type 5 E6 oncoprotein represses the transforming growth factor β signaling pathway by binding to SMAD3. J. Virol. 80:12420-12424.
18. Palmiter, R.D., and S.D. Findley. 1995. Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc. EMBO J. 14:639-649.
19. Cousins, R.J., J.P. Liuzzi, and L.A. Lichten. 2006. Mammalian zinc transport, trafficking, and signals. J. Biol. Chem. 281:24085-24089.
20. Liuzzi, J.P., J.A. Bobo, L.A. Lichten, D.A. Samuelson, and R.J. Cousins. 2004. Responsive transporter genes within the murine intestinal-pancreatic axis form a basis of zinc homeostasis. Proc. Natl. Acad. Sci. USA. 101:14355-14360.
21. Bi, Y., R.D. Palmiter, K.M. Wood, and Q. Ma. 2004. Induction of metallothionein I by phenolic antioxidants requires metal-activated transcription factor 1 (MTF-1) and zinc. Biochem. J. 380:695-703.
22. Berendji, D., V. Kolb-Bachofen, K.L. Meyer, O. Grapenthin, H. Weber, V. Wahn, and K.-D. Krönke. 1997. Nitric oxide mediates intracytoplasmic and intranuclear zinc release. FEBS Lett. 405:37-41.
23. Haase, H., and D. Beyersmann. 2002. Intracellular zinc distribution and transport in C6 rat glioma cells. Biochem. Biophys. Res. Commun. 296:923-928.
24. Lam, Y.W., L. Trinkle-Mulcahy, and A.I. Lamond. 2005. The nucleolus. J. Cell Sci. 118:1335-1337.
25. Yamasaki, S., K. Sakata-Sogawa, A. Hasegawa, T. Suzuki, K. Kabu, E. Sato, T. Kurosaki, S. Yamashita, M. Tokunaga, K. Nishida, and T. Hirano. 2007. Zinc is a novel intracellular second messenger. J. Cell Biol. 177:637-645.
26. Eom, S.J., E.Y. Kim, J.E. Lee, H.J. Kang, J. Shim, S.U. Kim, B.J. Gwag, and E.J. Choi. 2001. Zn(2+) induces stimulation of the c-Jun N-terminal kinase signaling pathway through phosphoinositide 3-Kinase. Mol. Pharmacol. 59:981-986.
27. Nonnenmacher, M., J. Salmon, Y. Jacob, G. Orth, and F. Breitburd. 2006. Cottontail rabbit papillomavirus E8 protein is essential for wart formation and provides new insights into viral pathogenesis. J. Virol. 80:4890-4900.
28. Orth, G. 2006. Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin. Immunol. 18:362-374.
29. Hoeller, D., B. Huppertz, T.C. Roos, P. Poblete Gutiérrez, H.F. Merk, J. Frank, and F.K. Jugert. 2001. An improved and rapid method to construct skin equivalents from hair follicles and fibroblasts. Exp. Dermatol. 10:264-271.
30. Palmiter, R.D. 2004. Protection against zinc toxicity by metallothionein and zinc transporter 1. Proc. Natl. Acad. Sci. USA. 101:4918-4923.